Skip to main content
GaldermaTechnical update

Galderma presented new three-year Nemluvio® data showing deep and lasting atopic dermatitis skin lesions and itch responses in patients aged 12 and older.

Source: Autobound Signal API · 72 signals tracked for Galderma · updated

Get Galderma's live signals in Claude or ChatGPT, or by API

AskWhat changed at Galderma this week? Use Autobound signals for galderma.com.

Source

galderma.com

What changed on the page

Added press release: “Fall Clinical 2026: Galderma presents new three-year Nemluvio® data showing deep and lasting skin lesion and itch responses in patients with atopic dermatitis aged 12 and older.”

galderma.com/news-archiveRead the full source

Extracted by Autobound

From the Signal API record
Signal
Technical update

What this signalsWebsite changes often show new positioning, products or customers.

Page
/news-archive

The full record

From the Signal API record

Details

Why it matters
Long-term efficacy and response data strengthen Nemluvio® credibility for atopic dermatitis and can support sales of the product to physicians and healthcare providers.

Extraction

Relevance
88%
Detected
Oct 20, 2026
signal_type
website-intelligence
signal_subtype
technicalUpdate

Use this data

Get every website changes signal for Galderma and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Galderma this week?”

  2. Send it to your own tools

    The Signal API returns website changes signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full website-intelligence record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/26b73d90-a4d4-5854-81e9-26aea615060e returns this record as JSON. POST /v1/companies/enrich returns every signal for galderma.com.

{
  "signal_id": "26b73d90-a4d4-5854-81e9-26aea615060e",
  "signal_type": "website-intelligence",
  "signal_subtype": "technicalUpdate",
  "detected_at": "2026-10-20T00:00:00+00:00",
  "company": {
    "name": "Galderma",
    "domain": "galderma.com"
  },
  "data": {
    "summary": "Galderma presented new three-year Nemluvio® data showing deep and lasting atopic dermatitis skin lesions and itch responses in patients aged 12 and older.",
    "evidence": "Added press release: “Fall Clinical 2026: Galderma presents new three-year Nemluvio® data showing deep and lasting skin lesion and itch responses in patients with atopic dermatitis aged 12 and older.”",
    "relevance": 0.88,
    "source_url": "https://www.galderma.com/news-archive",
    "impact_rationale": "Long-term efficacy and response data strengthen Nemluvio® credibility for atopic dermatitis and can support sales of the product to physicians and healthcare providers."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.